Eleonora Petti, Serena Di Vito, Roberto Dinami, Manuela Porru, Stefano Marchesi, Jeroen Lohuis, Pasquale Zizza, Sara Iachettini, Erica Salvati, Carmen D'Angelo, Angela Rizzo, Carmen Maresca, Flora Ascione, Anna Di Benedetto, Simonetta Buglioni, Andrea Sacconi, Paola Ostano, Qingsen Li, Antonella Stoppacciaro, Carlo Leonetti, Jacco van Rheenen, Paolo Maiuri, Giorgio Scita, Annamaria Biroccio
{"title":"TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.","authors":"Eleonora Petti, Serena Di Vito, Roberto Dinami, Manuela Porru, Stefano Marchesi, Jeroen Lohuis, Pasquale Zizza, Sara Iachettini, Erica Salvati, Carmen D'Angelo, Angela Rizzo, Carmen Maresca, Flora Ascione, Anna Di Benedetto, Simonetta Buglioni, Andrea Sacconi, Paola Ostano, Qingsen Li, Antonella Stoppacciaro, Carlo Leonetti, Jacco van Rheenen, Paolo Maiuri, Giorgio Scita, Annamaria Biroccio","doi":"10.1038/s41419-025-07415-4","DOIUrl":null,"url":null,"abstract":"<p><p>The Telomere Repeat-Binding factor 2 (TRF2) contributes to cancer progression by both telomere-dependent and independent mechanisms, including immune escape and angiogenesis. Here, we found that TRF2, through its Basic domain, directly interacts with Emerin forming a complex, including Lamin A/C, Lamin B1, SUN1, and SUN2. Importantly, TRF2 association with the inner nuclear membrane is functional to the proper establishment of cell polarity, finally promoting productive 1D and 3D migration in triple negative breast cancer cells (TNBC). In line with this, a spontaneous model of TNBC metastasis, combined with intravital imaging, allowed us to demonstrate that TRF2 promotes cell migration at the primary tumor site and is required for the early steps of the metastatic cascade. In human breast cancers, aberrantly elevated TRF2 expression positively correlates with cancer progression, metastasis, and poor prognosis, identifying TRF2 as a potential target for novel therapeutic strategies against TNBC.</p>","PeriodicalId":9734,"journal":{"name":"Cell Death & Disease","volume":"16 1","pages":"224"},"PeriodicalIF":8.1000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11955551/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Death & Disease","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s41419-025-07415-4","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The Telomere Repeat-Binding factor 2 (TRF2) contributes to cancer progression by both telomere-dependent and independent mechanisms, including immune escape and angiogenesis. Here, we found that TRF2, through its Basic domain, directly interacts with Emerin forming a complex, including Lamin A/C, Lamin B1, SUN1, and SUN2. Importantly, TRF2 association with the inner nuclear membrane is functional to the proper establishment of cell polarity, finally promoting productive 1D and 3D migration in triple negative breast cancer cells (TNBC). In line with this, a spontaneous model of TNBC metastasis, combined with intravital imaging, allowed us to demonstrate that TRF2 promotes cell migration at the primary tumor site and is required for the early steps of the metastatic cascade. In human breast cancers, aberrantly elevated TRF2 expression positively correlates with cancer progression, metastasis, and poor prognosis, identifying TRF2 as a potential target for novel therapeutic strategies against TNBC.
端粒重复结合因子2 (TRF2)通过端粒依赖和独立机制参与癌症进展,包括免疫逃逸和血管生成。在这里,我们发现TRF2通过其Basic结构域直接与Emerin相互作用,形成一个复合物,包括Lamin a /C、Lamin B1、SUN1和SUN2。重要的是,TRF2与核膜的关联对细胞极性的正确建立起作用,最终促进三阴性乳腺癌细胞(TNBC)的生产性1D和3D迁移。与此相一致的是,一个自发的TNBC转移模型,结合活体成像,使我们能够证明TRF2促进原发肿瘤部位的细胞迁移,并且是转移级联的早期步骤所必需的。在人类乳腺癌中,TRF2表达异常升高与癌症进展、转移和不良预后呈正相关,这使TRF2成为针对TNBC的新治疗策略的潜在靶点。
期刊介绍:
Brought to readers by the editorial team of Cell Death & Differentiation, Cell Death & Disease is an online peer-reviewed journal specializing in translational cell death research. It covers a wide range of topics in experimental and internal medicine, including cancer, immunity, neuroscience, and now cancer metabolism.
Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following:
Experimental medicine
Cancer
Immunity
Internal medicine
Neuroscience
Cancer metabolism